JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard Intermediate-Term Corporate Bond ETF
VCIT
|
+$3.46B |
| 2 |
Microsoft
MSFT
|
+$2.83B |
| 3 |
Eli Lilly
LLY
|
+$2.1B |
| 4 |
Broadcom
AVGO
|
+$1.33B |
| 5 |
Stryker
SYK
|
+$1.24B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard S&P 500 ETF
VOO
|
+$3.18B |
| 2 |
iShares Core S&P 500 ETF
IVV
|
+$2.39B |
| 3 |
iShares Core S&P Mid-Cap ETF
IJH
|
+$2.35B |
| 4 |
Alphabet (Google) Class C
GOOG
|
+$2.07B |
| 5 |
iShares 7-10 Year Treasury Bond ETF
IEF
|
+$1.5B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 26.04% |
| 2 | Technology | 20.48% |
| 3 | Healthcare | 9.65% |
| 4 | Financials | 9.27% |
| 5 | Consumer Discretionary | 8.86% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
6001
iShares Global Materials ETF
MXI
$424M
| $19.6K | ﹤0.01% |
224
| – | – |
2021 Q2
10 quarters
|
|
6002
CALL
Viatris
VTRS
$20.1B
| $19.5K | ﹤0.01% |
+1,800
| New | +$17.2K |
2023 Q4
0 quarters
|
|
|
WBX
6003
Wallbox
WBX
$63.8M
| $19.4K | ﹤0.01% |
+555
| New | +$19.9K |
2023 Q4
0 quarters
|
|
6004
AYTU BioPharma
AYTU
$22.7M
| $19.4K | ﹤0.01% |
6,835
+4,647
| +212% | +$12.8K |
2023 Q2
2 quarters
|
|
|
EQC.PRD
6005
DELISTED
Equity Commonwealth 6 1/2% Series D Cumulative Convertible Preferred Shares
EQC.PRD
| $19.4K | ﹤0.01% |
770
+270
| +54% | +$6.71K |
2021 Q4
8 quarters
|
|
6006
CALL
ARK Blockchain & Fintech Innovation ETF
ARKF
$834M
| $19.3K | ﹤0.01% |
700
| – | – |
2023 Q2
2 quarters
|
|
6007
Seanergy Maritime Holdings
SHIP
$376M
| $19.2K | ﹤0.01% |
2,457
+663
| +37% | +$4.14K |
2023 Q3
1 quarter
|
|
6008
Sagimet Biosciences
SGMT
$582M
| $19.2K | ﹤0.01% |
3,541
| – | – |
2023 Q3
1 quarter
|
|
|
AFDM
6009
First Trust Exchange-Traded Fund III First Trust Active Factor International ETF
AFDM
$160M
| $19K | ﹤0.01% |
310
| – | – |
2023 Q3
1 quarter
|
|
|
RNLX
6010
DELISTED
Renalytix plc American Depositary Shares
RNLX
| $18.8K | ﹤0.01% |
48,329
-21,660
| -31% | -$17.3K |
2021 Q1
11 quarters
|
|
6011
AMCON Distributing
DIT
| $18.7K | ﹤0.01% |
144
-81
| -36% | -$10K |
2021 Q3
9 quarters
|
|
6012
POET Technologies
POET
$1.32B
| $18.4K | ﹤0.01% |
+19,690
| New | +$34.5K |
2023 Q4
0 quarters
|
|
6013
First Trust Multi Cap Value AlphaDEX Fund
FAB
$159M
| $18.4K | ﹤0.01% |
235
-137
| -37% | -$9.76K |
2023 Q1
3 quarters
|
|
|
ABPWW
6014
DELISTED
Abpro Holdings Warrant
ABPWW
| – | – |
0
| – | – |
2023 Q4
0 quarters
|
|
|
CHW
6015
Calamos Global Dynamic Income Fund
CHW
$510M
| $18.2K | ﹤0.01% |
3,157
+2,180
| +223% | +$12.1K |
2022 Q3
5 quarters
|
|
|
BFIN
6016
DELISTED
BankFinancial
BFIN
| $18.1K | ﹤0.01% |
1,764
+508
| +40% | +$4.6K |
2023 Q2
2 quarters
|
|
6017
Innovator US Equity Ultra Buffer ETF April
UAPR
$159M
| $18.1K | ﹤0.01% |
659
-82,924
| -99% | -$2.19M |
2023 Q3
1 quarter
|
|
6018
PennantPark Floating Rate Capital
PFLT
$692M
| $18K | ﹤0.01% |
1,488
-1,637
| -52% | -$17.9K |
2013 Q2
42 quarters
|
|
6019
CION Investment
CION
$352M
| $17.9K | ﹤0.01% |
1,580
+1
| +0.1% | +$11 |
2022 Q3
5 quarters
|
|
6020
Northern Trust STOXX US ESG Select ETF
ESG
$135M
| $17.9K | ﹤0.01% |
154
| – | – |
2023 Q3
1 quarter
|
|
6021
New Horizon Aircraft Ltd
HOVRW
$9.99M
| – | – |
0
| – | – |
2023 Q4
0 quarters
|
|
|
CLCO
6022
DELISTED
Cool Company
CLCO
| $17.8K | ﹤0.01% |
1,400
-164,823
| -99% | -$2.13M |
2023 Q1
3 quarters
|
|
6023
Milestone Pharmaceuticals
MIST
$102M
| $17.8K | ﹤0.01% |
10,662
-233,694
| -96% | -$634K |
2021 Q4
8 quarters
|
|
6024
Nuveen California Municipal Value Fund
NCA
$278M
| $17.8K | ﹤0.01% |
+1,987
| New | +$16.6K |
2023 Q4
0 quarters
|
|
|
IDE
6025
Voya Infrastructure, Industrials and Materials Fund
IDE
$182M
| $17.6K | ﹤0.01% |
1,731
-2,404
| -58% | -$22.7K |
2023 Q3
1 quarter
|
|
Similar funds
JP Morgan Chase's Q4 2023 Portfolio in Review
As of Q4 2023, JP Morgan Chase held 8,129 positions worth $1.04T, up 15% from $906B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
JP Morgan Chase's Q4 2023 filing shows 701 new, 3,661 increased, 2,247 reduced and 617 closed positions. Its largest new stake was JPMorgan US Tech Leaders ETF: 3,149,069 shares worth $185M. The largest sale was Vanguard S&P 500 ETF, an estimated $3.18B.
By sector, the portfolio is most concentrated in Miscellaneous at 26% of assets, down from 26% a quarter earlier, followed by Technology and Healthcare.
- JP Morgan Chase's largest Q4 2023 buy was JPMorgan US Tech Leaders ETF: 3,149,069 shares worth $185M.
- JP Morgan Chase added most to Vanguard Intermediate-Term Corporate Bond ETF in Q4 2023, an estimated $3.46B increase.
- JP Morgan Chase's biggest Q4 2023 reduction was Vanguard S&P 500 ETF, cutting an estimated $3.18B.
- JP Morgan Chase fully exited Activision Blizzard in Q4 2023, selling an estimated $1.06B.
- JP Morgan Chase's ten largest holdings make up 20% of its $1.04T portfolio in Q4 2023.
- JP Morgan Chase opened 701 new positions and closed 617 in Q4 2023.
- JP Morgan Chase's portfolio value rose 15% quarter-over-quarter to $1.04T.
Based on JP Morgan Chase's 13F filing for Q4 2023, filed 12 Feb 2024.